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Condensation: Middle cerebral artery Doppler and umbilico-cerebral ratio are less strongly 
associated with outcome than birth weight or gestation at delivery in early fetal growth 
restriction.  
Short version of title: Middle cerebral artery Doppler in early fetal growth restriction. 
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Abstract 
BACKGROUND 
Reduced fetal middle cerebral artery Doppler impedance is associated with hypoxemia in 
fetal growth restriction. This finding is increasingly recommended to guide delivery timing 
decisions despite a paucity of evidence from prospective studies.  
OBJECTIVES 
The aim of this study was to determine whether there is an association between middle 
cerebral artery Doppler impedance and its ratio with the umbilical artery in relation to 
neonatal and 2-year infant outcome. Additionally we sought to explore which ratio is more 
informative for clinical use. 
STUDY DESIGN 
This is a secondary analysis from TRUFFLE, a prospective multicenter randomized 
management study on different antenatal monitoring strategies (ductus venosus Doppler 
changes and computerized cardiotocography short term variation) in fetal growth restriction 
diagnosed between 26+0 and 31+6 weeks. We analyzed women with middle cerebral artery 
Doppler measurement at study entry and within 1 week before delivery, and with complete 
postnatal follow-up (374/503). The primary outcome was survival without 
neurodevelopmental impairment at 2 years corrected for prematurity. Neonatal outcome 
was defined as survival until first discharge home without severe neonatal morbidity. Z-
scores were calculated for middle cerebral artery pulsatility index and both umbilico-
cerebral and cerebro-placental ratios. Odds ratios of Doppler parameter z-scores for 
neonatal and 2-year infant outcome were calculated by multivariable logistic regression 
analysis adjusted for gestational age and birth weight p50 ratio.  
RESULTS  
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Higher middle cerebral artery pulsatility index at inclusion but not within 1 week before 
delivery was associated with neonatal survival without severe morbidity (odds ratio 1.24; 
95% confidence interval 1.02 to 1.52). Middle cerebral artery pulsatility index Z-score and 
umbilico-cerebral ratio Z-score at inclusion were associated with 2-year survival with normal 
neurodevelopmental outcome (odds ratio 1.33; 95% confidence interval 1.03-1.72 and odds 
ratio 0.88; 95% confidence interval 0.78-0.99, respectively) as were gestation at delivery and 
birthweight p50 ratio (odds ratio 1.41; 95% confidence interval 1.20-1.66, and odds ratio 
1.86; 95% confidence interval 1.33-2.60, respectively). When comparing cerebro-placental 
ratio against umbilico-cerebral ratio, the incremental range of the cerebro-placental ratio 
tended towards zero whereas the umbilico-cerebral ratio tended towards infinity as the 
values became more abnormal. 
CONCLUSIONS 
In a monitoring protocol based on ductus venosus and cardiotocography in early fetal 
growth restriction, the impact of middle cerebral artery Doppler and its ratios on outcome is 
modest and less marked than birth weight and delivery gestation. It is unlikely that middle 
cerebral artery Doppler and its ratios are informative in optimizing timing of delivery in early 
fetal growth restriction. The umbilico-cerebral ratio allows for a better differentiation in the 
abnormal range than the cerebro-placental ratio.  
 
Keywords: middle cerebral artery, cerebro-placental ratio; CPR; Doppler velocimetry; 
umbilico-cerebral ratio; neonatal; intrauterine growth restriction. 
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Introduction 
There is renewed interest in the predictive value for adverse perinatal outcome of the 
middle cerebral artery (MCA) Doppler, particularly in the third trimester.1 The so-called 
‘brain sparing’ effect, as evidenced by a low pulsatility index (PI), refers to vasodilatation of 
cerebral vessels in response to fetal hypoxemia particularly in fetal growth restriction.2-4 
Ratios of cerebral (carotid or MCA) to central or peripheral (aortic or umbilical) impedance 
are more closely related to antenatal blood gases and pH,4 discriminate better between 
normal and risk pregnancies5-7 and are more predictive of perinatal fetal distress than 
individual Doppler parameters.8 In order to consider the opposite changes occurring in the 
MCA (reduced impedance) and umbilical artery (increased impedance) with progressive 
hypoxemia, the umbilico-cerebral ratio5-7 and its inverse, the cerebro-umbilical also known 
as the cerebro-placental ratio have been established.7,9-12 Up to now, most publications 
report on the cerebro-placental rather than the umbilico-cerebral ratio but the advantage of 
one over the other is unclear. 
Although brain sparing has been traditionally considered as a protective phenomenon in 
fetal hypoxemia, its presence or deterioration of the ratio of the MCA Doppler PI to umbilical 
artery may be associated with increased risk of adverse neurodevelopmental outcome, both 
in term and preterm pregnancies with fetal growth restriction.13 The interpretation of these 
findings is problematic, especially for preterm fetal growth restriction, due to paucity of 
prospective good-quality studies with adequate sample size and long-term follow-up. The 
aim of this study is to investigate the association of the MCA PI, cerebro-placental and 
umbilico-cerebral ratios, normalized for gestational age, with neonatal and 2-year infant 
outcome in a large predefined group with early fetal growth restriction as part of the 
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multicenter TRUFFLE study.14,15 We also investigated which MCA related ratio is most 
informative for clinical use. 
 
Material and methods 
This is a secondary analysis of the association between MCA PI, cerebro-placental and 
umbilico-cerebral ratios with the neonatal and 2-year infant outcome from the TRUFFLE 
study. The TRUFFLE study design has been described earlier.15 
In short, this was a prospective multicenter randomized management trial conducted in 20 
European tertiary care centers from 2005 to 2010. The randomized trial was registered with 
the International Standard Randomized controlled Trial Number Register – 
ISRCTN56204499). Eligible women had singleton pregnancies between 26 and 31+6 
gestational weeks diagnosed with fetal growth restriction, defined as a fetal abdominal 
circumference <10th centile16 and abnormal umbilical artery Doppler (PI>95th centile)7 with 
or without absent or reversed end-diastolic flow.  Estimated fetal weight had to be >500 
grams,17 and the ductus venosus waveform normal with a PI<95th centile18 and a normal 
computerized cardiotocography short term variation.19 Following informed consent, 
participants were randomly assigned to one of three groups in a 1:1:1 ratio to determine the 
timing of delivery. These groups were: 1) monitoring and delivery according to computerized 
cardiotocography short term variation criteria (short term variation <3.5 milliseconds (msec) 
at <29 weeks or <4 msec at ≥29 weeks); 2a) delivery based on early changes in the ductus 
venosus PI (>95th centile); and 2b) delivery based on late changes of the ductus venosus (no 
or reverse A wave flow). For further details on patient monitoring in the TRUFFLE study see 
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Supplementary Appendix. The study was ratified by the ethics committees of all participating 
units, and all participants gave their written informed consent.  
The primary outcome was survival without neurodevelopmental impairment at 2 years 
corrected for prematurity (Supplementary Appendix).  
Neonatal outcome was defined as survival until first discharge home without severe 
neonatal morbidity (Supplementary Appendix).  
For this analysis, we included only women who had measurements of the middle cerebral 
and umbilical arteries both at inclusion and within 1 week before delivery, and who had 
complete 2-year follow-up. If there were more MCA Doppler measurements within the last 
week before delivery only the last one was selected.  
Z-scores were calculated for MCA PI, cerebro-placental and umbilico-cerebral ratios using 
reference data by Arduini.20 For birthweight classification an expected (median) weight was 
calculated, adjusted for gestational age, maternal weight, length and ethnic descent.21  This 
allowed calculation of a birthweight to p50 ratio. 
Both absolute values and Z-scores of MCA PI, cerebro-placental and umbilico-cerebral ratios 
at study inclusion were compared for neonatal and 2-year infant outcome. This analysis was 
repeated using the last Doppler values. A delta value for the Doppler parameter Z-scores was 
calculated by subtracting the first measurement from the last, dividing this by the number of 
days in between and multiply this ratio by 100: Delta ratio = 100 x (last – first) / Interval in 
days. This value was similarly compared for outcome.  
Anova, Chi-square, Wilcoxon signed rank or Kruskal-Wallis test were used as appropriate. 
Levene test was used to assess for homogeneity of variables. Odds ratios with 95% 
confidence intervals (CI) of each MCA related Doppler Z-scores parameter for neonatal 
outcome (survival until the first discharge home without severe morbidity) and 2-year infant 
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outcome (survival without neurodevelopmental impairment at 2 years) were calculated by 
multivariable logistic regression analysis with adjustment for gestational age and birth 
weight p50 ratio. Data are presented as number, percentage (%), mean and standard 
deviation (SD) or median and interquartile range (IQR) as required. IBM SPSS statistics 
version 22 (New York, U.S.A.) was used for statistical calculation. 
 
Results 
Table 1 shows the selection process for this post-hoc analysis. Women lost to follow up 
(60/503, 12%) were excluded. All women with known outcome (n=443; 88%) had MCA 
Doppler at inclusion, and 380 (76%) in the last week before delivery. Additionally, we 
excluded 4 patients with fetal death who had refused intervention, and 2 women whose 
infants died shortly after birth due to a lethal congenital abnormality (trisomy 18, complex 
cardiac abnormality) (“inevitable deaths”, Table 1). The study population available for 
analysis was 374 (74%) women. 
Absolute values and Z-scores of MCA PI, cerebro-placental and umbilico-cerebral ratios are 
shown in Table 2 specified for 2-year infant outcome categories. Absolute values and Z-
scores of all Doppler parameters at study inclusion were significantly different between 
outcome categories. However, notwithstanding the significant difference between first and 
last Doppler parameters, neither the difference between the first and last measurement, nor 
the last values were significantly associated with 2-year infant outcome. Other parameters 
that differed significantly among 2-year infant outcome groups were estimated fetal weight, 
birth weight, birth weight p50, gestational age at inclusion and at delivery, nulliparity, Apgar 
score at 5 minutes <7, infant sex, and severe neonatal morbidity (Table 2). 
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Figure 1 shows the Z-scores of the first and last Doppler measurements: the umbilico-
cerebral ratio has a wider distribution in the abnormal range, with more abnormal outliers, 
than the cerebro-placental ratio. The median of the differences between the first and last 
measurement was significantly different from zero for all three Doppler parameters 
(p<0.001, Wilcoxon signed rank test).  
Figure 2a shows the odds ratios for neonatal outcome adjusted for gestational age at 
delivery and birth weight p50 ratio (see also Table S1 in the Supplementary Appendix). The 
MCA PI Z-score at study inclusion was the only Doppler related parameter with a significant 
association with neonatal survival without severe morbidity (odds ratio 1.24; 95%CI 1.02 to 
1.52) together with gestational age at delivery (odds ratio 1.69; 95%CI 1.46-1.95). 
Figure 2b shows the adjusted odds ratios for 2-year infant outcome (see also Table S2 in the 
Supplementary Appendix). Among all Doppler criteria, only MCA PI Z-score and umbilico-
cerebral ratio Z-score at study inclusion were significantly associated with 2-year infant 
survival with normal neurodevelopmental outcome (odds ratio 1.33; 95%CI 1.03-1.72 and 
odds ratio 0.88; 95%CI 0.78-0.99, respectively). Gestational age at delivery and birthweight 
p50 ratio were also significantly associated with a normal outcome (odds ratio 1.41; 95%CI 
1.20-1.66, and odds ratio 1.86; 95%CI 1.33-2.60, respectively).  
The cerebro-placental ratio did not reach statistical significance despite the fact that it is the 
inverse of the umbilico-cerebral ratio, and that Z-scores were calculated from the same 
reference table. To explore this further, we plotted umbilico-cerebral ratio against cerebro-
placental ratio and observed that in the abnormal range for cerebro-placental ratio (<1), the 
incremental change is far more compressed than for umbilico-cerebral ratio (>1) (Figure 3). 
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Comment 
Principal findings of the study 
We show that, for MCA related Doppler parameters, only MCA PI Z-score at study inclusion 
is associated with neonatal survival until discharge home without severe morbidity, and that 
MCA PI and the umbilico-cerebral ratio Z-scores at study inclusion are associated with 2-year 
infant survival without neurodevelopmental impairment. Cerebro-placental ratio Z-score at 
study inclusion, MCA PI, umbilico-cerebral and cerebro-placental ratio Z-sores shortly before 
birth and the change of these parameters with time were not associated with neonatal or 2-
year infant outcome.  Moreover, our data show that gestational age at delivery remains the 
most important factor in determining neonatal survival without adverse outcome and, 
together with birthweight, in determining 2-year infant outcome without 
neurodevelopmental impairment. 
Results of the study in the context of other observations 
Brain sparing in early fetal growth restriction and neonatal and 2-year infant outcome. In this 
study of fetuses whose mothers were enrolled into a large prospective randomized 
management trial of early fetal growth restriction, fetuses with less severe cerebral 
vasodilatation at study inclusion had a higher chance of avoiding mortality and severe 
neonatal morbidity, and of 2-year survival without neurodevelopmental impairment. This 
observation is consistent with recent reports of an increased prevalence of adverse 
outcomes in fetal growth restriction with cerebral vasodilatation,13 suggesting that, although 
cerebral vasodilatation is thought to be protective, its presence reveals fetal hypoxemia22 
that might be associated with brain damage.  
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Importantly, in our study, gestational age and birth weight were the main factors in 
determining neonatal and infant outcome, respectively. Moreover, similarly to other studies 
that evaluated brain sparing and delivery in early growth restriction,23,24 the MCA PI 
measured close to delivery and its change over time had no impact on neonatal or 2-year 
infant outcome. These findings confirm that in early fetal growth restriction the impact of 
placental disease on neonatal and infant outcome depends mainly on gestational age and 
severity of growth restriction.23,24 The impact of MCA Doppler at study inclusion on neonatal 
and 2-year infant outcome though not strong was mechanistically interesting. Given that it is 
impossible to know in advance whether a MCA Doppler measurement is the last for a given 
fetus, the finding is likely to be of very limited clinical utility and apparently not useful for the 
decision when to deliver the fetus. 
Middle cerebral artery related ratios. For MCA related ratios we found significant differences 
for absolute values and Z-scores at study inclusion, but these differences were not observed 
close to delivery. After adjustment for other relevant factors, a significant association 
persisted only between umbilico-cerebral ratio at study inclusion and 2-year survival without 
neurodevelopmental impairment, not for its inverse the cerebro-placental ratio.  
Several reports have shown the advantage of umbilico-cerebral5-6 and cerebro-placental 
ratios7,25-29  over an isolated MCA PI measurement in differentiating fetal growth restriction 
from small for gestational age or appropriately grown fetuses, and in predicting  adverse 
neonatal outcome in fetal growth restriction. However, most studies were performed in 
both early and late fetal growth restriction while in our cohort only pregnancies with early 
(<32 weeks) fetal growth restriction were included, characterized by both smallness and 
umbilical Doppler abnormalities. Early and late fetal growth restriction are associated with 
different feto-placental hemodynamic profiles.  
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Though one study revealed an association between abnormal umbilico-cerebral ratio and 
adverse neurodevelopmental infant outcome,30 our findings suggest that this association is 
dominated by gestational age and birthweight. 
Interestingly, we found no association between change in MCA related Doppler parameters 
with time, or measured close to delivery, and neonatal or 2-year infant outcome suggesting 
that it is not the change in MCA related Doppler parameters that impacts on the outcome in 
early fetal growth restriction. In fact, it has been shown that the MCA PI may be abnormal 
for many weeks before the fetus becomes compromised.31,32 Further, the fact that changes 
in MCA, the cerebro-placental or umbilico-cerebral ratios Z-scores with respect to time were 
not associated with normal outcome at 2 years suggests that there is no rationale for 
delivering babies on the basis of MCA Doppler impairment. It is in fact plausible that the 
reverse may be true given the stronger effect of gestational age and birth weight on 
outcome. 
It might be of interest that the umbilico-cerebral ratio Z-score at study inclusion showed an 
association with the 2-year infant outcome, but the cerebro-placental ratio Z-score did not. 
We have shown that although both ratios describe the same phenomenon they behave 
differently in the abnormal range. This can be explained mathematically: as umbilical and 
MCA Doppler become abnormal, the umbilical artery PI increases and MCA PI falls. 
Therefore, the umbilico-cerebral ratio will increase and tend towards an asymptote leading 
to infinity, while the cerebro-placental ratio will tend towards zero (Figure 3). A worsening in 
the fetal condition will have a very small effect on the cerebro-placental ratio but conversely 
a large one on the umbilico-cerebral ratio. Therefore, the umbilico-cerebral ratio 
discriminates better in the context of progressive fetal hypoxia. 
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Strengths and limitations  
 
Our results are robust for several reasons. First of all, this is by far the largest cohort (n=374) 
of early fetal growth restriction in which MCA related parameters were evaluated in relation 
to neonatal and 2-year infant outcome. Moreover, women enrolled in the TRUFFLE study 
were carefully phenotyped: the high majority of these babies represented a true growth 
restriction as reflected not only by the low estimated fetal weight but also a high umbilical 
artery PI. Furthermore, all women were followed by a clearly defined monitoring protocol 
and all investigators were experienced in fetal Doppler assessment. None of MCA related 
Doppler parameters played a part in obstetric decision-making and their values were 
adjusted for relevant parameters associated with neonatal and infant outcome, such as 
gestational age at study entry or at delivery, estimated fetal weight or birth weight, fetal sex, 
and others.  
Factors affecting the generalizability of the results include that not all women entered into 
the study were considered as not all underwent MCA Doppler assessment within one week 
before delivery. Of eligible women, we were able to consider three quarters. Again, this is 
unlikely to be associated with a systematic bias as MCA Doppler was not a component of 
delivery decision-making. 
The fact that all fetuses with early growth restriction already had increased umbilical artery 
PI at inclusion is different from a situation in late fetal growth restriction when umbilical 
artery waveforms may still be within the normal range. Therefore, we caution in generalizing 
these results to later gestation.  
Conclusions and clinical implications 
In term pregnancies an association between cerebro-placental ratio and adverse neonatal 
outcome has been found not only in late fetal growth restriction,33,34 but also in fetuses with 
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normal birth weight.9 An association has been described between lower fetal cerebro-
placental ratio and the need for operative delivery for fetal compromise at term with 
suspected late placental diffusion disturbances regardless of the fetal size.35 We interpret 
these findings with caution since retrospective results showing a relationship between MCA 
Doppler related parameters and short-term outcome cannot be considered as robust 
evidence on how to influence perinatal practice.36 
Several studies evaluated the association between MCA related Doppler parameters and 
short-term outcome in early fetal growth restriction.1,13,37 However, there is a paucity of 
prospective studies that evaluated long-term neurodevelopmental outcome in a large cohort 
of preterm growth restricted babies.30 In fact, the majority of studies examined the role of 
cerebral vasodilatation on long-term outcome in preterm fetuses, both growth restricted 
and appropriate for gestational age.38-40 
 Although this study was not designed to evaluate the role of MCA related Doppler 
parameters in delivery decision-making, based on our results there is no compelling 
evidence to support its use in the follow up or timing of delivery in early fetal growth 
restriction. Given that we have shown that monitoring and delivery based on late ductus 
venosus changes combined with computerized cardiotocography confers the best 2-year 
neurodevelopmental outcome,15 it is important to wait if possible before delivering the 
fetus.  Our data show that the gestational age at delivery in early fetal growth restriction 
remains the most important factor in determining neonatal and 2-year infant outcome. This 
accords with the findings of a study of 17,148 babies born at 22-32 weeks. Though not 
limited to growth restriction, gestation, birth weight and sex were the most important 
predictors of survival without morbidity.41  
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In conclusion, despite some associations with adverse outcome, it is unlikely that MCA PI, 
cerebro-placental and umbilico-cerebral ratios will be helpful for targeting the best time of 
delivery in early fetal growth restriction monitored by short term fetal heart rate variation 
and ductus venosus PI. Where indicated, the umbilico-cerebral ratio is preferable for clinical 
use over cerebro-placental ratio as this allows better differentiation in the abnormal range. 
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Tables  
Table 1. Selection of the final study group (n=374) by stepwise application of the inclusion criteria  
 
 cCTG-STV DV p95 DV no A Total 
All (Row%) 166 (33%) 167 (33%) 170 (34%) 503 
With known outcome at 2 years  144 (87%) 142 (85%) 157 (92%) 443 (88%) 
 Perinatal and infant death <2 years † 13 (9%) 11 (8%) 17 (11%) 41 (9%) 
 Neurological impairment* 20 (15%) 12 (9%) 7 (5%) 39 (10%) 
Doppler within 1 week before delivery  121 (73%) 118 (71%) 141 (83%) 380 (76%) 
               Inevitable death excluded 1 (1%) 1 (1%) 4 (3%) 6 (2%) 
Study population 120 (72%) 117 (70%) 137 (81%) 374 (74%) 
 Perinatal and infant death <2 years † 10 (8%) 10 (9%) 12 (9%) 32 (9%) 
 Neurological impairment* 15 (14%) 11 (10%) 6 (5%) 32 (10%) 
† Including 2 deaths after first discharge home and before 2 years.  
*The denominator is represented by infants with known outcome minus perinatal and infant death 
<2 years. 
cCTG-STV: computerized cardiotocography short-term variation; DV p95: early changes in the ductus 
venosus (DV-PI>95th percentile); DV no A: late changes in ductus venosus (no or reverse A wave 
flow). 
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Table 2. Demographic, obstetric, Doppler and neonatal data specified for 2-year infant outcome 
categories for women with a Doppler measurement at the inclusion and within 1 week before 
delivery 
 
Normal neuro-
development 
outcome 
Abnormal neuro-
development 
outcome 
Death < 2 years Total 
Number of women (Row%) 310 (83%) 32 (9%) 32 (9%) 374 
Allocation cCTG-STV 95 (31%) 15 (13%) 10 (8%) 120 (32%) 
  DV p95 96 (31%) 11 (9%) 10 (9%) 117 (31%) 
  DV noA 119 (38%) 6 (4%) 12 (9%) 137 (37%) 
Maternal age 31 (5) 31 (5) 30 (6) 31 (5) 
Nulliparous* 192 (62%) 16 (50%) 27 (84%) 235 (63%) 
Gestational age at inclusion* 29.3 (28.0-30.2) 29.0 (26.9-30.7) 27.9 (27.0-28.7) 29.1 (27.9-30.1) 
Estimated fetal weight* 895 (213) 831 (237) 718 (182) 875 (218) 
Estimated fetal weight p50 ratio * 0.65 (0.10) 0.62 (0.08) 0.61 (0.08) 0.64 (0.10) 
Gestational hypertensive disease 237 (77%) 25 (78%) 24 (75%) 286 (77%) 
Doppler parameters at study inclusion     
MCA-PI * 1.4 (1.2-1.7) 1.3 (1.1-1.5) 1.4 (1.1-1.5) 1.4 (1.2-1.7) 
MCA-PI Z-score * -2.0 (-2.6 to -1.1) -2.2 (-3.3 to -1.7) -2.1 (-3.1 to -1.6) -2.0 (-2.7 to -1.1) 
UCR * 1.3 (1.1-1.6) 1.6 (1.2-1.9) 1.4 (1.2-2.2) 1.4 (1.1-1.7) 
UCR Z-score * 2.7 (1.8-3.9) 3.6 (2.1-5.0) 3.0 (2.2-5.9) 2.8 (1.9-4.2) 
CPR * 0.7 (0.6-0.9) 0.6 (0.5-0.8) 0.7 (0.5-0.8) 0.7 (0.6-0.9) 
CPR Z-score * -2.0 (-2.4 to -1.7) -2.3 (-2.6 to -1.8) -2.1 (-2.7 to -1.8) -2.1 (-2.4 to -1.7) 
Doppler parameters (last) within 1 
week before delivery † 
    
MCA-PI  1.3 (1.1-1.5) 1.4 (1.1-1.5) 1.3 (1.1-1.6) 1.3 (1.1-1.5) 
MCA-PI Z-score -2.3 (-2.9 to -1.5) -2.2 (-3.2 to -1.7) -2.4 (-3.1 to -1.5) -2.3 (-2.9 to -1.6) 
UCR  1.5 (1.2-2.0) 1.6 (1.2-2.3) 1.7 (1.3-2.4) 1.5 (1.2-2.1) 
UCR Z-score  3.4 (2.4-5.3) 3.8 (2.3-6.3) 4.0 (2.5-6.6) 3.5 (2.4-5.6) 
CPR 0.7 (0.5-0.8) 0.6 (0.4-0.8) 0.6 (0.4-0.8) 0.7 (0.5-0.8) 
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CPR Z-score -2.2 (-2.6 to -1.9) -2.3 (-2.7 to -1.9) -2.4 (-2.8 to -2.0) -2.2 (-2.6 to -1.9) 
Doppler difference between last and 
first, adjusted for number of days in 
between and multiplied by 100 
    
Delta MCA-PI ratio Z-score  0.0 (-8.3 to 0.0) 0.0 (-2.9 to 1.3) 0.0 (-0.9 to 2.3) 0.0 (-6.6 to 0.0) 
Delta UCR Z-score 0.0 (0.0-16.3) 0.0 (0.0-18.1) 0.0 (0.0-18.2) 0.0 (0.0-16.8) 
Delta CPR Z-score 0.0 (-4.9 to 0.0) 0.0 (-2.9 to 0.0) 0.0 (-4.9 to 0.0) 0.0 (-4.5 to 0.0) 
Neonatal outcome     
Fetal death ---- ---- 7 (22%) 7 (2%) 
Gestational age at delivery * 30.6 (29.1-32.0) 30.1 (28.4-31.4) 28.6 (27.8-29.8) 30.4 (29.0-31.9) 
Birth weight * 1000 (269) 870 (266) 759 (233) 968(276) 
Birth weight p50 ratio* 0.59 (0.09) 0.55 (0.08) 0.56 (0.10) 0.59 (0.10) 
Male sex* 149 (48%) 20 (63%) 18 (56%) 187 (50%) 
Apgar score 5’ <7 * 24 (8%) 8 (25%) 5 (16%) 37 (10%) 
pH <7.0 (n=359) 2 (1%) 1 (4%) 1(5%) 4 (1%) 
Severe neonatal morbidity* 80 (26%) 14 (44%) 24 (75%) 118 (32%) 
Neonatal death   24 (75%) 24 (6%) 
Late death <2 years   1 (3%) 1 (0%) 
Data are presented as number (percentage), mean (standard deviation) or median (interquartile 
range). 
*p<0.05 (Anova, Chi-square or Kruskal-Wallis test).  
† Last measurements differing significantly from the first measurements (p<0.05; Wilcoxon signed 
rank test). 
cCTG-STV: computerized cardiotocography short-term variation; DV p95: early changes in the ductus 
venosus (DV-PI>95th percentile);  
DV no A: late changes in ductus venosus (no or reverse A wave flow);  
MCA-PI: middle cerebral artery pulsatility index;  
UCR: umbilico-cerebral ratio;  
CPR: cerebro-placental ratio.  
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Figure legends 
Figure 1. Box plots of middle cerebral artery related Doppler parameters Z-scores. 
The umbilico-cerebral ratio (UCR), the cerebro-placental ratio (CPR) and middle cerebral artery 
(MCA) pulsatility index at inclusion (first) and within 1 week before delivery (last), n=374.  
Differences between first and last measurements are all statistically significant (p<0.001, Wilcoxon 
signed rank test). 
 
 
Figure 2. Odds ratios with 95% confidence intervals for neonatal and 2-year infant outcome. 
The upper panel (a) represents odds ratios for neonatal outcome (survival until the first discharge 
home without severe morbidity) and the lower panel (b) represents odds ratios for 2-year infant 
outcome (survival without neurological impairment at 2 years) of the Z-scores of the middle cerebral 
artery (MCA) pulsatility index, umbilico-cerebral ratio (UCR) and cerebro-placental ratio (CPR) at 
inclusion (first) and within one week before delivery (last), adjusted for birthweight p50 ratio and 
gestational age. The odds ratios of the adjusting parameters are shown below the horizontal line.  
DV p95: early changes in the ductus venosus (DV-PI>95th percentile);  
DV no A: late changes in ductus venosus (no or reverse A wave flow). 
 
Figure 3: Umbilico-cerebral ratio (UCR) versus cerebro-placental ratio (CPR) at study inclusion in 
the TRUFFLE study (n=374). 
The shaded area defines an abnormal test with a cut-off at 1.0. 
 
 
 
 
 
 
